HEADER HYDROLASE 11-JUL-24 9G35 TITLE THE HIV PROTEASE INHIBITOR LOPINAVIR BINDING TO THE ACTIVE SITE OF TITLE 2 CRYPHONECTRIA PARASITICA ENDOTHIAPEPSIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOTHIAPEPSIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ASPARTATE PROTEASE; COMPND 5 EC: 3.4.23.22 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CRYPHONECTRIA PARASITICA; SOURCE 3 ORGANISM_COMMON: CHESTNUT BLIGHT FUNGUS; SOURCE 4 ORGANISM_TAXID: 5116 KEYWDS ASPARTIC PROTEASE, DRUG DEVELOPMENT, INHIBITOR, X-RAY KEYWDS 2 CRYSTALLOGRAPHIC SCREENING, CHESTNUT BLIGHT FUNGUS, PROTEASE MODEL, KEYWDS 3 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.FALKE,J.M.SENST,S.GUENTHER,A.MEENTS REVDAT 2 13-NOV-24 9G35 1 REMARK REVDAT 1 24-JUL-24 9G35 0 JRNL AUTH S.FALKE,J.M.SENST,S.GUENTHER,A.MEENTS JRNL TITL THE HIV PROTEASE INHIBITOR LOPINAVIR BINDING TO THE ACTIVE JRNL TITL 2 SITE OF CRYPHONECTRIA PARASITICA ENDOTHIAPEPSIN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18_3861 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.75 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.420 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 101579 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.150 REMARK 3 R VALUE (WORKING SET) : 0.150 REMARK 3 FREE R VALUE : 0.159 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.970 REMARK 3 FREE R VALUE TEST SET COUNT : 1999 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.7500 - 3.6200 0.97 7074 151 0.1329 0.1206 REMARK 3 2 3.6100 - 2.8700 0.97 7046 141 0.1569 0.1599 REMARK 3 3 2.8700 - 2.5100 0.98 7175 139 0.1617 0.1832 REMARK 3 4 2.5100 - 2.2800 0.99 7195 140 0.1600 0.1601 REMARK 3 5 2.2800 - 2.1100 0.97 7106 147 0.1453 0.1552 REMARK 3 6 2.1100 - 1.9900 0.94 6898 134 0.1517 0.1599 REMARK 3 7 1.9900 - 1.8900 0.97 7098 126 0.1489 0.1604 REMARK 3 8 1.8900 - 1.8100 0.98 7151 141 0.1593 0.1851 REMARK 3 9 1.8100 - 1.7400 0.98 7161 147 0.1502 0.1665 REMARK 3 10 1.7400 - 1.6800 0.99 7168 147 0.1503 0.1658 REMARK 3 11 1.6800 - 1.6300 0.99 7180 127 0.1428 0.1895 REMARK 3 12 1.6300 - 1.5800 0.99 7250 152 0.1476 0.1930 REMARK 3 13 1.5800 - 1.5400 0.96 6987 143 0.1433 0.1767 REMARK 3 14 1.5400 - 1.5000 0.98 7091 164 0.1493 0.1697 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.117 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 14.540 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 11.07 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.49 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 2586 REMARK 3 ANGLE : 0.822 3532 REMARK 3 CHIRALITY : 0.057 411 REMARK 3 PLANARITY : 0.006 454 REMARK 3 DIHEDRAL : 8.226 428 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9G35 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-JUL-24. REMARK 100 THE DEPOSITION ID IS D_1292139895. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAY-24 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PETRA III, DESY REMARK 200 BEAMLINE : P11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.033190 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 101583 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 42.750 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.7700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.54 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.18_3861 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.45 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24% (W/V) PEG 4000, 0.1 M AMMONIUM REMARK 280 ACETATE AND 0.1 M SODIUM ACETATE PH 4.6 WERE MIXED WITH AN EQUAL REMARK 280 VOLUME OF 6 MG/ML ENDOTHIAPEPSIN SOLUTION. MICROSEEDING WAS REMARK 280 APPLIED. AFTER 2 DAYS CRYSTALS WERE SOAKED WITH THE LIGAND IN REMARK 280 RESERVOIR SOLUTION IN THE PRESENCE OF 5% (V/V) DMSO., VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.75950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12880 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 129 -169.41 -77.88 REMARK 500 ALA A 320 174.47 -59.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 887 DISTANCE = 5.81 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 9FVO RELATED DB: PDB REMARK 900 RELATED ID: 9G34 RELATED DB: PDB DBREF 9G35 A 1 330 UNP P11838 CARP_CRYPA 90 419 SEQRES 1 A 330 SER THR GLY SER ALA THR THR THR PRO ILE ASP SER LEU SEQRES 2 A 330 ASP ASP ALA TYR ILE THR PRO VAL GLN ILE GLY THR PRO SEQRES 3 A 330 ALA GLN THR LEU ASN LEU ASP PHE ASP THR GLY SER SER SEQRES 4 A 330 ASP LEU TRP VAL PHE SER SER GLU THR THR ALA SER GLU SEQRES 5 A 330 VAL ASP GLY GLN THR ILE TYR THR PRO SER LYS SER THR SEQRES 6 A 330 THR ALA LYS LEU LEU SER GLY ALA THR TRP SER ILE SER SEQRES 7 A 330 TYR GLY ASP GLY SER SER SER SER GLY ASP VAL TYR THR SEQRES 8 A 330 ASP THR VAL SER VAL GLY GLY LEU THR VAL THR GLY GLN SEQRES 9 A 330 ALA VAL GLU SER ALA LYS LYS VAL SER SER SER PHE THR SEQRES 10 A 330 GLU ASP SER THR ILE ASP GLY LEU LEU GLY LEU ALA PHE SEQRES 11 A 330 SER THR LEU ASN THR VAL SER PRO THR GLN GLN LYS THR SEQRES 12 A 330 PHE PHE ASP ASN ALA LYS ALA SER LEU ASP SER PRO VAL SEQRES 13 A 330 PHE THR ALA ASP LEU GLY TYR HIS ALA PRO GLY THR TYR SEQRES 14 A 330 ASN PHE GLY PHE ILE ASP THR THR ALA TYR THR GLY SER SEQRES 15 A 330 ILE THR TYR THR ALA VAL SER THR LYS GLN GLY PHE TRP SEQRES 16 A 330 GLU TRP THR SER THR GLY TYR ALA VAL GLY SER GLY THR SEQRES 17 A 330 PHE LYS SER THR SER ILE ASP GLY ILE ALA ASP THR GLY SEQRES 18 A 330 THR THR LEU LEU TYR LEU PRO ALA THR VAL VAL SER ALA SEQRES 19 A 330 TYR TRP ALA GLN VAL SER GLY ALA LYS SER SER SER SER SEQRES 20 A 330 VAL GLY GLY TYR VAL PHE PRO CYS SER ALA THR LEU PRO SEQRES 21 A 330 SER PHE THR PHE GLY VAL GLY SER ALA ARG ILE VAL ILE SEQRES 22 A 330 PRO GLY ASP TYR ILE ASP PHE GLY PRO ILE SER THR GLY SEQRES 23 A 330 SER SER SER CYS PHE GLY GLY ILE GLN SER SER ALA GLY SEQRES 24 A 330 ILE GLY ILE ASN ILE PHE GLY ASP VAL ALA LEU LYS ALA SEQRES 25 A 330 ALA PHE VAL VAL PHE ASN GLY ALA THR THR PRO THR LEU SEQRES 26 A 330 GLY PHE ALA SER LYS HET AB1 A 401 46 HET PGE A 402 10 HET EDO A 403 4 HET PG4 A 404 13 HET EDO A 405 4 HET PG4 A 406 13 HETNAM AB1 N-{1-BENZYL-4-[2-(2,6-DIMETHYL-PHENOXY)-ACETYLAMINO]-3- HETNAM 2 AB1 HYDROXY-5-PHENYL-PENTYL}-3-METHYL-2-(2-OXO-TETRAHYDRO- HETNAM 3 AB1 PYRIMIDIN-1-YL)-BUTYRAMIDE HETNAM PGE TRIETHYLENE GLYCOL HETNAM EDO 1,2-ETHANEDIOL HETNAM PG4 TETRAETHYLENE GLYCOL HETSYN AB1 ABT-378; LOPINAVIR HETSYN EDO ETHYLENE GLYCOL FORMUL 2 AB1 C37 H48 N4 O5 FORMUL 3 PGE C6 H14 O4 FORMUL 4 EDO 2(C2 H6 O2) FORMUL 5 PG4 2(C8 H18 O5) FORMUL 8 HOH *387(H2 O) HELIX 1 AA1 THR A 49 VAL A 53 5 5 HELIX 2 AA2 THR A 60 SER A 64 5 5 HELIX 3 AA3 SER A 113 GLU A 118 1 6 HELIX 4 AA4 PHE A 130 ASN A 134 5 5 HELIX 5 AA5 THR A 143 LYS A 149 1 7 HELIX 6 AA6 ALA A 150 LEU A 152 5 3 HELIX 7 AA7 PRO A 228 ALA A 237 1 10 HELIX 8 AA8 PRO A 274 TYR A 277 5 4 HELIX 9 AA9 GLY A 306 LYS A 311 1 6 SHEET 1 AA1 9 LYS A 68 SER A 78 0 SHEET 2 AA1 9 SER A 84 VAL A 96 -1 O VAL A 89 N LEU A 70 SHEET 3 AA1 9 TYR A 17 ILE A 23 -1 N GLN A 22 O SER A 95 SHEET 4 AA1 9 GLY A 3 PRO A 9 -1 N THR A 8 O ILE A 18 SHEET 5 AA1 9 GLY A 167 PHE A 171 -1 O PHE A 171 N GLY A 3 SHEET 6 AA1 9 VAL A 156 ASP A 160 -1 N THR A 158 O ASN A 170 SHEET 7 AA1 9 PHE A 314 ASN A 318 -1 O PHE A 317 N PHE A 157 SHEET 8 AA1 9 THR A 324 ALA A 328 -1 O ALA A 328 N PHE A 314 SHEET 9 AA1 9 THR A 184 ALA A 187 -1 N THR A 186 O LEU A 325 SHEET 1 AA213 LYS A 68 SER A 78 0 SHEET 2 AA213 SER A 84 VAL A 96 -1 O VAL A 89 N LEU A 70 SHEET 3 AA213 LEU A 99 VAL A 112 -1 O VAL A 106 N TYR A 90 SHEET 4 AA213 LEU A 41 VAL A 43 1 N LEU A 41 O GLU A 107 SHEET 5 AA213 GLY A 124 GLY A 127 -1 O LEU A 125 N TRP A 42 SHEET 6 AA213 GLN A 28 ASP A 35 1 N ASP A 35 O LEU A 126 SHEET 7 AA213 TYR A 17 ILE A 23 -1 N VAL A 21 O LEU A 30 SHEET 8 AA213 GLY A 3 PRO A 9 -1 N THR A 8 O ILE A 18 SHEET 9 AA213 GLY A 167 PHE A 171 -1 O PHE A 171 N GLY A 3 SHEET 10 AA213 VAL A 156 ASP A 160 -1 N THR A 158 O ASN A 170 SHEET 11 AA213 PHE A 314 ASN A 318 -1 O PHE A 317 N PHE A 157 SHEET 12 AA213 THR A 324 ALA A 328 -1 O ALA A 328 N PHE A 314 SHEET 13 AA213 THR A 184 ALA A 187 -1 N THR A 186 O LEU A 325 SHEET 1 AA3 7 ALA A 269 ILE A 273 0 SHEET 2 AA3 7 PHE A 262 VAL A 266 -1 N PHE A 262 O ILE A 273 SHEET 3 AA3 7 GLU A 196 VAL A 204 -1 N ALA A 203 O THR A 263 SHEET 4 AA3 7 LYS A 210 ALA A 218 -1 O LYS A 210 N TYR A 202 SHEET 5 AA3 7 ASN A 303 PHE A 305 1 O PHE A 305 N ILE A 217 SHEET 6 AA3 7 LEU A 225 LEU A 227 -1 N TYR A 226 O ILE A 304 SHEET 7 AA3 7 ILE A 294 SER A 296 1 O GLN A 295 N LEU A 225 SHEET 1 AA4 4 LYS A 243 SER A 245 0 SHEET 2 AA4 4 GLY A 250 PRO A 254 -1 O GLY A 250 N SER A 245 SHEET 3 AA4 4 SER A 289 GLY A 292 -1 O CYS A 290 N PHE A 253 SHEET 4 AA4 4 ASP A 279 PRO A 282 -1 N GLY A 281 O PHE A 291 SSBOND 1 CYS A 255 CYS A 290 1555 1555 2.03 CISPEP 1 THR A 25 PRO A 26 0 -8.75 CISPEP 2 SER A 137 PRO A 138 0 6.23 CRYST1 45.539 73.519 53.410 90.00 110.14 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021959 0.000000 0.008053 0.00000 SCALE2 0.000000 0.013602 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019942 0.00000